{"disease":{"id":"cancers-with-ret-alterations","name":"cancers with ret alterations"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03052569","title":"Expanded Access to RXDX-105 for Cancers With RET Alterations","phase":"","overall_status":"NO_LONGER_AVAILABLE","enrollment_count":null,"lead_sponsor_name":"Hoffmann-La Roche","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}